Resultado de búsqueda
16 de dic. de 2021 · The phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is a major signaling pathway in various types of cancer. 1 It controls hallmarks of cancer, including cell survival,...
18 de ago. de 2023 · Abstract. The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression.
4 de nov. de 2019 · The PI3K–AKT signalling network is activated downstream of receptor tyrosine kinases (RTKs), cytokine receptors, integrins and G protein-coupled receptors (GPCRs) and plays a central role in...
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Exp Mol Pathol. 2022 Aug:127:104787. doi: 10.1016/j.yexmp.2022.104787. Epub 2022 May 27. Authors. Mohammad Rafi Khezri 1 , Reza Jafari 2 , Keyvan Yousefi 3 , Naime Majidi Zolbanin 4. Affiliations.
24 de sept. de 2020 · The PI3K/AKT signaling pathway inhibitor LY294002 blocked the drug transport of HT29RDB overexpressing MRP1 protein in colon cancer cells 114.
1 de ago. de 2022 · Phosphatidylinositol-3-kinase/AKT (PI3K/AKT) signaling pathway is activated upon interaction of ligands such as insulin and growth factors with their receptors. The binding of extracellular growth factors to receptor tyrosine kinases (RTKs) induces dimerization and phosphorylation of the monomers.
5 de ago. de 2021 · The PI3K/AKT pathway is one of the most frequently over-activated intracellular pathways in several human cancers. This pathway, acting on different downstream target proteins, contributes to the carcinogenesis, proliferation, invasion, and metastasis of tumour cells.
